Percutaneous ethanol injection for treatment of adrenal metastasis from hepatocellular carcinoma

OBJECTIVE. With the improved prognosis of patients with hepatocellular carc inoma, the likelihood of diagnosing adrenal metastasis has increased. We pe rformed percutaneous ethanol injection for adrenal metastasis in seven pati ents and evaluated its efficacy. CONCLUSION. Percutaneous ethanol injection was successfully performed in ni ne nodules in seven patients. During follow-up, six nodules in five patient s showed no increase in size. Four patients were alive 6-28 months after in jection, one patient died of hepatic failure, one of brain metastasis, and one of multiple metastases. Percutaneous ethanol injection can be an altern ative treatment for adrenal metastasis of hepatocellular carcinoma.